May 18, 2017 / 1:10 PM / 3 months ago

BRIEF-Biogen acquires Remedy Pharmaceuticals' late-stage drug cirara

May 18 (Reuters) - Biogen Inc

* Biogen acquires Remedy Pharmaceuticals' late-stage drug cirara

* Biogen Inc says Biogen made an upfront payment of $120 million to remedy and may also pay additional milestone payments and royalties

* Says Biogen made an upfront payment of $120 million to remedy and may also pay additional milestone payments and royalties Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below